/Companies

MyoDOPA

also invests · investor profile

3 known investors

Find your way into MyoDOPA

Sign up to see every warm intro you have to MyoDOPA

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MyoDOPA team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

UK Research and Innovation (UKRI) is a UK public body that invests over £9 billion of public money each year into research and innovation across disciplines including the arts, humanities, social sciences, biological and environmental sciences, physics and engineering.

Investors · 3

Companies House · registry record

View on Companies House ↗
Registered name
MYODOPA LIMITED
Company number
10145857
Status
Dissolved
Company type
Private limited company
Incorporated
25 Apr 2016
Dissolved
14 Jun 2022
Registered office
C/O Cmb Partnership Limited 7 Wey Court, Mary Road, Guildford, GU1 4QU
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 31 May 2021

Current officers

  • Michael Mcdonald — director, appointed 25 Apr 2016

Source: Companies House public register · retrieved 23 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does MyoDOPA do?
UK Research and Innovation (UKRI) is a UK public body that invests over £9 billion of public money each year into research and innovation across disciplines including the arts, humanities, social sciences, biological and environmental sciences, physics and engineering.
Who are MyoDOPA's investors?
MyoDOPA's investors include Future Planet Capital, Innovate UK Investor Partnerships, SFC Capital.